The severity of neural invasion is a crucial prognostic factor in rectal cancer independent of neoadjuvant radiochemotherapy.
Ceyhan
Güralp O
GO
Department of Surgery, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany
Liebl
Florian
F
Maak
Matthias
M
Schuster
Tibor
T
Becker
Karen
K
Langer
Rupert
R
Demir
Ihsan Ekin
IE
Hartel
Mark
M
Friess
Helmut
H
Rosenberg
Robert
R
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000032:analysis; D002272:Carcinoembryonic Antigen / Q000032:analysis; D016009:Chi-Square Distribution; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D020360:Neoadjuvant Therapy; D009361:Neoplasm Invasiveness / Q000473:pathology*; D009367:Neoplasm Staging; D011379:Prognosis; D016016:Proportional Hazards Models; D012004:Rectal Neoplasms / Q000188:drug therapy / Q000473:pathology* / Q000532:radiotherapy / Q000601:surgery; D012007:Rectum / Q000294:innervation*; D012720:Severity of Illness Index; D018709:Statistics, Nonparametric
D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen